Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis

Published:2013-07-10 Issue:7 Volume:8 Page:e68152
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Price Huw,Dunn David,Pillay Deenan,Bani-Sadr Firouze,de Vries-Sluijs Theodora,Jain Mamta K.,Kuzushita Noriyoshi,Mauss Stefan,Núñez Marina,Nüesch Reto,Peters Marion,Reiberger Thomas,Stephan Christoph,Tan Lionel,Gilson Richard

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

2. British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010;G Brook;HIV Med,2010

3. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses;G Woo;Gastroenterology,2010

4. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement;D Moher;PLoS Med,2009

5. Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand;A Avihingsanon;Antivir Ther,2010

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?;Sexually Transmitted Infections;2024-07-26

2. Follow-up and estimation of steatotic liver disease using transient elastography in patients with human immunodeficiency virus;Kanzo;2024-04-01

3. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on therapy;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

4. Increasing hepatitis B vaccination coverage and decreasing hepatitis B co‐infection prevalence among people with HIV‐1 in Germany, 1996–2019. Results from a cohort study primarily in men who have sex with men;HIV Medicine;2023-10-02

5. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial;The Lancet HIV;2023-10